European equities traded in the US as American depositary receipts were higher late Tuesday morning, rising 0.50% to 1,356.26 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biotech firm Evaxion Biotech (EVAX), which soared 36.3%, followed by biopharmaceutical company DBV Technologies (DBVT), which rose 10%. They were followed by financial services companies Banco Bilbao Vizcaya Argentaria (BBVA) and Banco Santander (SAN), which were up 3.3% and 3.6%, respectively.
The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP), which fell 1.2%, followed by consumer goods company Unilever (UL) and pharmaceutical company Novo Nordisk (NVO), which were down 0.4% and 0.1% respectively.
From the UK and Ireland, the gainers were led by Akari Therapeutics (AKTX) and biopharmaceutical companies TC Biopharm (TCBP), which rose 5.9% and 3.3% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group (MREO) and Verona Pharma (VRNA), which increased 2% and 1% respectively.
The decliners from the UK and Ireland were led by telecommunications operator Vodafone (VOD) and biopharmaceutical company NuCana (NCNA), which dropped 5% and 3.4% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which lost 0.2%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.